Atlas Trials

Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets

Clinical trial NCT06431438 · COMPLETED

Trial details

NCT number
NCT06431438
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2021-10-01
Primary completion
2023-11-20
Enrollment
759

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.